Purchases and Sales Made in Q1 2022 in Nls Pharmaceutics LTD Wt Pur C (NLSPW)
This table provides information about the institutional ownership of Nls Pharmaceutics LTD Wt Pur C (NLSPW) during Q1 2022. The information is specifically focused on institutions that hold shares of NLS PHARMACEUTICS LTD WT PUR C.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 16, 2022
Q1 2022
|
Empery Asset Management, LP
New York, NY |
BUY
|
- |
150KNew |
$30K - $75K
|
150K
$1.5K
|
|
|
May 13, 2022
Q1 2022
|
Warberg Asset Management LLC
Winnetka, IL |
BUY
|
- |
12.9KNew |
$2.58K - $6.45K
|
12.9K
$129
|
|
|
May 09, 2022
Q1 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
May 16, 2022
Q1 2022
|
Ubs Group Ag
|
SELL
|
- |
-645- 24.48% |
$129 - $323
|
1.99K
$19.9
|
|
|
May 09, 2022
Q1 2022
|
Bank Julius Baer & Co. Ltd, Zurich
|
SELL
|
- |
-7.37KClosed |
$1.47K - $3.69K
|
0
$0
|
|
|
May 16, 2022
Q1 2022
|
Hudson Bay Capital Management LP
Greenwich, CT |
SELL
|
- |
-100K- 50.0% |
$20K - $50K
|
100K
$1K
|